Skip to content

Zoetis ZTS Financing Cash Flow

Financing Cash Flow at other companies

Merck & Co. logo
Merck & Co.MRK
-$2.98B+48.2%
Neogen logo
NeogenNEOG
-$451K+68.0%
Idexx Laboratories logo
Idexx LaboratoriesIDXX
-$211.43M+36.0%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$2.3M
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
-$65M-225%
Tractor Supply Company logo
Tractor Supply CompanyTSCO
-$230.42M+61.9%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$32.49B-51.7%
Enterprise value$40.54B-44.1%
P/E12.3×-13.7×
P/S3.4×-3.8×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's financing cash flow?
Zoetis (ZTS) reported financing cash flow of -$840M in Q1 2026.
How has Zoetis's financing cash flow changed year-over-year?
Zoetis's financing cash flow decreased by 24.1% year-over-year, from -$677M to -$840M.
What is the long-term trend for Zoetis's financing cash flow?
Over 3 years (2021 to 2025), Zoetis's financing cash flow has grown at a 0.1% compound annual growth rate (CAGR), from -$1.86B to -$1.87B.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.